MRI引导下胸腹部经皮穿刺活检:我们的初步经验
作者认为MRI引导对US或CT难以接近的病变是可行且准确的替代方法。
要点
- 恶性病变检出47/57(82%),良性10/57(18%)。
- 无严重并发症,2例严重疼痛经保守处理。
核心结论
- 初步经验显示MRI引导胸腹部肿块活检技术可行且准确,患者与操作者舒适度好,尤其适用于US或CT难以接近的病变,可作为其他方法的有效替代。
研究设计与样本
- 前瞻性纳入2021年1月至2022年5月有MRI引导活检指征的患者,最终57例(男32例,平均年龄64±8岁)接受MRI引导经皮活检。
- 排除标准为有US或CT引导活检指征、经皮活检禁忌、无法平卧至少30分钟、幽闭恐惧症、重度肥胖或非MRI兼容装置。
- 活检由3名具有至少8年肿瘤介入放射学经验的介入放射科医师在介入MRI手术室完成,流行病学、临床、操作及组织病理学数据为回顾性收集。
诊断标准与关键数值
- 组织病理学证实恶性47/57(82%),良性10/57(18%)。
临床应用与阅片要点
- 整个操作平均耗时37分钟(范围28-65分钟),针在患者体内总时间平均10分钟(范围6-19分钟)。
- 无严重并发症,发生2例轻微并发症(严重疼痛),均经保守处理。
- 作者认为MRI引导可作为其他方法的有效替代,尤其适用于US或CT难以接近的病变。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: The aim of this study is to describe the technique and to report early results of thoraco-abdominal biopsies in the Interventional Magnetic Resonance Imaging Suite (IMRIS).
MATERIALS AND METHODS: We prospectively evaluated patients with indications for MRI-guided biopsy between January 2021 and May 2022. Exclusion criteria were indication for US-/CT-guided biopsy, contraindication to percutaneous biopsy, inability to lie flat for at least 30 min, claustrophobic, severe obesity, or non-MRI compatible devices. Biopsies were performed by 3 interventional radiologists, with at least 8 years of experience in oncological interventional radiology. Epidemiological, clinical, procedural, and histopathological data were retrospectively collected.
RESULTS: From an initial population of 117 patients, 57 patients (32 male, mean age 64 ± 8 y) were finally enrolled. All 57 patients suspected thoraco-abdominal malignant lesions finally underwent MRI-guided percutaneous biopsy. The mean duration of the entire procedure was 37 min (range 28-65 min); the mean duration of the total needle-in-patient time was 10 min (range 6-19 min). Technical and clinical success were obtained for all the biopsies performed. Malignancy was demonstrated in 47/57 (82%) cases and benignancy in the remaining 10/57 (18%) cases. No major complications were detected after the biopsies; two minor compliances (severe pain) occurred and were managed conservatively.
CONCLUSION: Our initial experience demonstrated the technical feasibility and the accuracy of MRI-guided biopsies of thoraco-abdominal masses. The reported data associated with the best comfort for the patient and for the operator make the use of MRI a valid alternative to other methods, especially in lesions that are difficult to approach via US or CT.
CLINICAL RELEVANCE STATEMENT: Interventional MRI is one of the most important innovations available for interventional radiologists. This method will broaden the diagnostic and therapeutic possibilities, allowing treatment of lesions up to now not approachable percutaneously. For this, it is necessary to start publishing the data of the few groups that are developing the method.
KEY POINTS: • To evaluate the use of MRI as a guide for percutaneous biopsies of various districts. • Our preliminary experience confirms experience demonstrated the technical feasibility and the accuracy of MRI-guided biopsies of thoraco-abdominal masses. • Interventional MRI can become the reference method for percutaneous biopsies in particular for lesions with difficult percutaneous approach.
引用
- Corradini, Polidori, Maresca, et al. MRI-guided thoraco-abdominal percutaneous needle biopsy: our initial experience. Eur Radiol. 2023. PMID: 37256353. doi:10.1007/s00330-023-09763-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。